{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T08:27:55Z","timestamp":1791361675298,"version":"4.3.1"},"reference-count":150,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Ocular Surface"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.jtos.2022.08.002","type":"journal-article","created":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T12:02:01Z","timestamp":1660046521000},"page":"128-141","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["5-Fluorouracil in primary, impending recurrent and recurrent pterygium: Systematic review of the efficacy and safety of a surgical adjuvant and intralesional antimetabolite"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7678-1067","authenticated-orcid":false,"given":"Brendon W.H.","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amitouj S.","family":"Sidhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian C.","family":"Francis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minas T.","family":"Coroneo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtos.2022.08.002_bib1","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S1542-0124(12)70103-9","article-title":"The pathogenesis of pterygium: current concepts and their therapeutic implications","volume":"6","author":"Chui","year":"2008","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2022.08.002_bib2","series-title":"Ocular surface disease: cornea, conjunctiva and tear film","first-page":"125","article-title":"Pterygium - chapter 18","author":"Coroneo","year":"2013"},{"key":"10.1016\/j.jtos.2022.08.002_bib3","series-title":"Cornea","article-title":"Management of recurrent pterygium - chapter 145","author":"Coroneo","year":"2022"},{"key":"10.1016\/j.jtos.2022.08.002_bib4","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.ajpath.2010.10.037","article-title":"Ophthalmic pterygium: a stem cell disorder with premalignant features","volume":"178","author":"Chui","year":"2011","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jtos.2022.08.002_bib5","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/ICL.0b013e318223394e","article-title":"Ultraviolet radiation and the anterior eye","volume":"37","author":"Coroneo","year":"2011","journal-title":"Eye Contact Lens"},{"key":"10.1016\/j.jtos.2022.08.002_bib6","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1136\/bjophthalmol-2017-310686","article-title":"Pterygia are indicators of an increased risk of developing cutaneous melanomas","volume":"102","author":"Crewe","year":"2018","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jtos.2022.08.002_bib7","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.jid.2020.11.012","article-title":"Xeroderma pigmentosum: a model for human premature aging","volume":"141","author":"Rizza","year":"2021","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jtos.2022.08.002_bib8","first-page":"30","article-title":"Conjunctivitis and pterygium associated with the American Indian type of polymorphous light eruption","volume":"23","author":"Fletcher","year":"1988","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.jtos.2022.08.002_bib9","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/eye.2011.322","article-title":"Fixation and its role in the causation, laterality and location of pterygium: a study in amblyopes and non-amblyopes","volume":"26","author":"Sudhalkar","year":"2012","journal-title":"Eye"},{"key":"10.1016\/j.jtos.2022.08.002_bib10","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1442-9071.1977.tb01738.x","article-title":"Pterygium, pinguecula and visual acuity","volume":"5","author":"Saad","year":"1977","journal-title":"Aust J Opthalmol"},{"key":"10.1016\/j.jtos.2022.08.002_bib11","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/j.1755-3768.1982.tb00602.x","article-title":"Pterygium, the dominant eye and the habit of closing one eye in sunlight","volume":"60","author":"Jensen","year":"1982","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.jtos.2022.08.002_bib12","first-page":"2592","article-title":"Influence of corneal shape on limbal light focusing","volume":"35","author":"Maloof","year":"1994","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2022.08.002_bib13","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jtos.2020.12.001","article-title":"Handing it to pterygium: explaining pterygium laterality","volume":"19","author":"Coroneo","year":"2021","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2022.08.002_bib14","series-title":"Conjunctival autograft for primary and recurrent pterygium: past, present, and future - chapter 7","author":"Coroneo","year":"2019"},{"key":"10.1016\/j.jtos.2022.08.002_bib15","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0161-6420(94)31270-X","article-title":"Pterygium recurrence time","volume":"101","author":"Hirst","year":"1994","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtos.2022.08.002_bib16","article-title":"Pterygium: an update on pathophysiology, clinical features, and management","volume":"13","author":"Shahraki","year":"2021","journal-title":"Ther Adv Ophthalmol"},{"key":"10.1016\/j.jtos.2022.08.002_bib17","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1159\/000493544","article-title":"Dry-eye disease in recurrent pterygium","volume":"61","author":"Tan","year":"2019","journal-title":"Ophthalmic Res"},{"key":"10.1016\/j.jtos.2022.08.002_bib18","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.ophtha.2006.02.026","article-title":"Efficacy of subconjunctival 5-fluorouracil and triamcinolone injection in impending recurrent pterygium","volume":"113","author":"Prabhasawat","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtos.2022.08.002_bib19","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1097\/ICO.0b013e318162af90","article-title":"Postoperative subconjunctival corticosteroid injection to prevent pterygium recurrence","volume":"27","author":"Paris Fdos","year":"2008","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2022.08.002_bib20","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0161-6420(00)00567-4","article-title":"Amniotic membrane transplantation after extensive removal of primary and recurrent pterygia","volume":"108","author":"Solomon","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtos.2022.08.002_bib21","doi-asserted-by":"crossref","first-page":"5","DOI":"10.5301\/ejo.5000004","article-title":"Topical cyclosporine A administration after pterygium surgery","volume":"22","author":"\u00d6z\u00fclken","year":"2012","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.jtos.2022.08.002_bib22","first-page":"185","article-title":"The effect of topical 0.05% cyclosporine in the prevention of recurrence following pterygium surgery","volume":"6","author":"Karadag","year":"2021","journal-title":"Beyoglu Eye J"},{"key":"10.1016\/j.jtos.2022.08.002_bib23","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1159\/000151740","article-title":"Topical cyclosporine A in the prevention of pterygium recurrence","volume":"222","author":"Yalcin Tok","year":"2008","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.jtos.2022.08.002_bib24","doi-asserted-by":"crossref","first-page":"881","DOI":"10.2147\/OPTH.S19469","article-title":"The effect of topical 0.05% cyclosporine on recurrence following pterygium surgery","volume":"5","author":"Turan-Vural","year":"2011","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.jtos.2022.08.002_bib25","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1136\/bjophthalmol-2017-310288","article-title":"Comparison among adjuvant treatments for primary pterygium: a network meta-analysis","volume":"102","author":"Fonseca","year":"2018","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jtos.2022.08.002_bib26","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/aos.13178","article-title":"Use of anti-vascular endothelial growth factor in the management of pterygium","volume":"95","author":"Mak","year":"2017","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.jtos.2022.08.002_bib27","first-page":"1126","article-title":"Bevacizumab as adjuvant therapy in the management of pterygium: a systematic review and Meta-analysis","volume":"10","author":"Liu","year":"2017","journal-title":"Int J Ophthalmol"},{"key":"10.1016\/j.jtos.2022.08.002_bib28","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1155\/2018\/4598173","article-title":"Efficacy and safety of bevacizumab in the treatment of pterygium: an updated meta-analysis of randomized controlled trials","volume":"2018","author":"Sun","year":"2018","journal-title":"Journal of Ophthalmology"},{"key":"10.1016\/j.jtos.2022.08.002_bib29","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ophtha.2012.06.066","article-title":"Options and adjuvants in surgery for pterygium: a report by the American Academy of Ophthalmology","volume":"120","author":"Kaufman","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtos.2022.08.002_bib30","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2165\/00003495-200767020-00005","article-title":"The clinical applications of fluorouracil in ophthalmic practice","volume":"67","author":"Abraham","year":"2007","journal-title":"Drugs"},{"key":"10.1016\/j.jtos.2022.08.002_bib31","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1001\/archopht.1995.01100110016008","article-title":"Inefficacy of low-dose intraoperative fluorouracil in the treatment of primary pterygium","volume":"113","author":"Maldonado","year":"1995","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jtos.2022.08.002_bib32","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1590\/S0004-27492000000200003","article-title":"Uso do 5-fluorouracil no intra-operatorio da cirurgia do pterigio [Intra-operative use of 5-fluorourcail in pterygium surgery]","volume":"63","author":"Schellini","year":"2000","journal-title":"Arq Bras Oftalmol"},{"key":"10.1016\/j.jtos.2022.08.002_bib33","first-page":"104","article-title":"Prevention of pterygium recurrence with intraoperative 5-fluorouracil","volume":"10","author":"Majeed","year":"2000","journal-title":"J Coll Physicians Surg Pak"},{"key":"10.1016\/j.jtos.2022.08.002_bib34","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/00003226-200308000-00007","article-title":"5-Fluorouracil as chemoadjuvant for primary pterygium surgery: preliminary report","volume":"22","author":"Akarsu","year":"2003","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2022.08.002_bib35","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/j.1742-1241.2004.00007.x","article-title":"5-fluorouracil vs. beta-irradiation in the prevention of pterygium recurrence","volume":"58","author":"Bekibele","year":"2004","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.jtos.2022.08.002_bib36","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1136\/bjo.2006.101956","article-title":"Postoperative subconjunctival 5-fluorouracil in the management of recurring pterygium","volume":"91","author":"Pherwani","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jtos.2022.08.002_bib37","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/00003226-200103000-00011","article-title":"Halting pterygium recurrence by postoperative 5-fluorouracil","volume":"20","author":"Pikkel","year":"2001","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2022.08.002_bib38","first-page":"130","article-title":"Effect of intralesional 5 fluorouracil injection in primary pterygium","volume":"32","author":"Khan","year":"2016","journal-title":"Pakistan J Med Sci"},{"key":"10.1016\/j.jtos.2022.08.002_bib39","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/eye.2013.135","article-title":"Intra-lesional 5 fluorouracil for the management of recurrent pterygium","volume":"27","author":"Said","year":"2013","journal-title":"Eye"},{"key":"10.1016\/j.jtos.2022.08.002_bib40","first-page":"559","article-title":"Comparison of primary versus recurrent pterygium after intralesional 5-Fluorouracil","volume":"66","author":"Malik","year":"2016","journal-title":"J Pakistan Med Assoc"},{"key":"10.1016\/j.jtos.2022.08.002_bib41","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1038\/s41433-019-0493-0","article-title":"Management of primary pterygium with intra-lesional injection of 5 flurouracil and bevacizumab (Avastin)","volume":"33","author":"Ghoz","year":"2019","journal-title":"Eye"},{"key":"10.1016\/j.jtos.2022.08.002_bib42","article-title":"Efficacy of 5-fluorouracil in the treatment of pterygium","volume":"13","author":"Shah","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.jtos.2022.08.002_bib43","first-page":"6","article-title":"Efficacy of intra-lesional injection of 5-fluorouracil in preventing progression of recurrent pterygium","volume":"18","author":"ul Haq","year":"2020","journal-title":"Ophthalmology Update"},{"key":"10.1016\/j.jtos.2022.08.002_bib44","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1177\/1120672120917335","article-title":"Postoperative treatment compliance rate and complications with two different protocols after pterygium excision and conjunctival autografting","volume":"31","author":"Sabater-Cruz","year":"2021","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.jtos.2022.08.002_bib45","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1177\/1120672118757428","article-title":"Ocular surface changes in recurrent pterygium cases post-operatively treated with 5-fluorouracil subconjunctival injections","volume":"29","author":"Garcia Tirado","year":"2019","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.jtos.2022.08.002_bib46","doi-asserted-by":"crossref","first-page":"4559","DOI":"10.1021\/ja01573a087","article-title":"The synthesis of 5-FLUOROPYRIMIDINES","volume":"79","author":"Duschinsky","year":"1957","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.jtos.2022.08.002_bib47","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/0002-9394(82)90239-2","article-title":"Fluorouracil for the treatment of massive periretinal proliferation","volume":"94","author":"Blumenkranz","year":"1982","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jtos.2022.08.002_bib48","first-page":"597","article-title":"[Non-freeze epikeratoplasty in recurrent pterygium]","volume":"86","author":"Radda","year":"1989","journal-title":"Fortschr Ophthalmol"},{"issue":"12","key":"10.1016\/j.jtos.2022.08.002_bib49","first-page":"1197","article-title":"Use of 5-fluorouracil in the treatment of recurrent pterygium. Our experience. [Italian]","volume":"117","author":"Carlentini","year":"1991","journal-title":"Ann Ottalmol Clin. Ocul"},{"key":"10.1016\/j.jtos.2022.08.002_bib50","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1097\/ICO.0000000000002091","article-title":"Practice patterns in the management of primary pterygium: a survey study","volume":"38","author":"Graue-Hernandez","year":"2019","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2022.08.002_bib51","doi-asserted-by":"crossref","first-page":"18","DOI":"10.4103\/njo.njo_6_20","article-title":"Pterygium surgeries at a tertiary hospital, southwest Nigeria: a four-year review","volume":"28","author":"Onnebune","year":"2020","journal-title":"Niger J Ophthalmol"},{"key":"10.1016\/j.jtos.2022.08.002_bib52","doi-asserted-by":"crossref","first-page":"7","DOI":"10.4103\/1110-9173.201625","article-title":"Intraoperative infiltration against topical application of 5-fluorouracil in pterygium treatment","volume":"18","author":"Ibrahim","year":"2017","journal-title":"Delta J Ophthalmol"},{"key":"10.1016\/j.jtos.2022.08.002_bib53","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/eye.2016.29","article-title":"5-Fluorouracil vs avastin as adjunct to conjunctival autograft in the surgical treatment of pterygium","volume":"30","author":"Bekibele","year":"2016","journal-title":"Eye"},{"key":"10.1016\/j.jtos.2022.08.002_bib54","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/s41433-019-0596-7","article-title":"Effect of multiple subconjunctival conbercept injections as an adjuvant to the surgical treatment of pterygium: a prospective randomised comparative 6-month follow-up study","volume":"34","author":"Zhang","year":"2020","journal-title":"Eye"},{"key":"10.1016\/j.jtos.2022.08.002_bib55","doi-asserted-by":"crossref","first-page":"372","DOI":"10.5935\/0004-2749.20190075","article-title":"Topical cyclosporine A 0.05% before and after surgery to prevent pterygium recurrence","volume":"82","author":"Meneghim","year":"2019","journal-title":"Arq Bras Oftalmol"},{"key":"10.1016\/j.jtos.2022.08.002_bib56","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3109\/08820538.2012.730101","article-title":"Intra-operative use of 5-Fluorouracil in pterygium surgery: a comparative study","volume":"28","author":"Silva","year":"2013","journal-title":"Semin Ophthalmol"},{"key":"10.1016\/j.jtos.2022.08.002_bib57","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/S0161-6420(87)33430-X","article-title":"Adjusting the dose of 5-fluorouracil after filtration surgery to minimize side effects","volume":"94","author":"Weinreb","year":"1987","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtos.2022.08.002_bib58","first-page":"2043","article-title":"The long-term effects of 5-fluorouracil and sodium butyrate on human Tenon's fibroblasts","volume":"33","author":"Khaw","year":"1992","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2022.08.002_bib59","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1590\/S0004-27492007000100014","article-title":"[Exposure of normal Tenon's capsule fibroblasts from pterygium to 5-fluorouracil and mitomycin C]","volume":"70","author":"Viveiros","year":"2007","journal-title":"Arq Bras Oftalmol"},{"key":"10.1016\/j.jtos.2022.08.002_bib60","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1001\/archopht.1992.01080200130040","article-title":"Five-minute treatments with fluorouracil, floxuridine, and mitomycin have long-term effects on human Tenon's capsule fibroblasts","volume":"110","author":"Khaw","year":"1992","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jtos.2022.08.002_bib61","first-page":"1849","article-title":"The use of antimetabolites as adjunctive therapy in the surgical treatment of pterygium","volume":"6","author":"Kareem","year":"2012","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.jtos.2022.08.002_bib62","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1007\/s00417-015-3068-1","article-title":"Antifibrotic effects of pirfenidone on Tenon's fibroblasts in glaucomatous eyes: comparison with mitomycin C and 5-fluorouracil","volume":"253","author":"Na","year":"2015","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.jtos.2022.08.002_bib63","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3109\/08820538.2013.835838","article-title":"Expression of vascular endothelial growth factor (VEGF) in macrophages, fibroblasts, and endothelial cells in pterygium treated with 5-Fluorouracil","volume":"30","author":"Hoyama","year":"2015","journal-title":"Semin Ophthalmol"},{"key":"10.1016\/j.jtos.2022.08.002_bib64","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1016\/S0161-6420(92)31721-X","article-title":"Inhibition of corneal epithelial wound healing. A comparative study of mitomycin C and 5-fluorouracil","volume":"99","author":"Ando","year":"1992","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtos.2022.08.002_bib65","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0161-6420(90)32456-9","article-title":"Effects of 5-fluorouracil and mitomycin C on cultured rabbit subconjunctival fibroblasts","volume":"97","author":"Yamamoto","year":"1990","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtos.2022.08.002_bib66","doi-asserted-by":"crossref","first-page":"565","DOI":"10.3109\/02713689209001812","article-title":"The effects of 5-fluorouracil and mitomycin C on the corneal endothelium","volume":"11","author":"Nuyts","year":"1992","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.jtos.2022.08.002_bib67","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1081\/CUS-120015900","article-title":"Evaluation of adverse ocular effects of 5-fluorouracil by using human corneal epithelial cell cultures","volume":"21","author":"Huhtala","year":"2002","journal-title":"Cutan Ocul Toxicol"},{"key":"10.1016\/j.jtos.2022.08.002_bib68","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/ICO.0b013e31825d56c1","article-title":"Cytostatic and cytotoxic effects of 5-fluorouracil on human corneal epithelial cells and keratocytes","volume":"32","author":"Midena","year":"2013","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2022.08.002_bib69","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1089\/jop.2015.0109","article-title":"5-Fluorouracil-Induced apoptosis changes in cultured corneal epithelial cells","volume":"32","author":"Wu","year":"2016","journal-title":"J Ocul Pharmacol Therapeut"},{"key":"10.1016\/j.jtos.2022.08.002_bib70","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ajo.2021.12.016","article-title":"Effects of mitomycin-C and 5-fluorouracil on ocular adnexal sebaceous carcinoma cells","volume":"40","author":"Gallo","year":"2022","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.jtos.2022.08.002_bib71","doi-asserted-by":"crossref","first-page":"480","DOI":"10.5958\/0973-9130.2019.00336.0","article-title":"Pterygium excision using bare sclera technique and adjunctive 5 -fluorouracil application","volume":"13","author":"Hassan","year":"2019","journal-title":"Indian J Forensic Med Toxicol"},{"key":"10.1016\/j.jtos.2022.08.002_bib72","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3906\/sag-1408-32","article-title":"Intraoperative application of 5-fluorouracil and mitomycin C as chemoadjuvants in primary pterygium surgery","volume":"46","author":"Altay","year":"2016","journal-title":"Turk J Med Sci"},{"key":"10.1016\/j.jtos.2022.08.002_bib73","doi-asserted-by":"crossref","first-page":"8581","DOI":"10.14260\/jemds\/1494","article-title":"Comparison of surgical techniques for pterygium using mitomycin-C or 5-fluorouracil as adjuncts","volume":"2","author":"Kuldeep","year":"2013","journal-title":"J Evol Med Dent Sci"},{"key":"10.1016\/j.jtos.2022.08.002_bib74","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/sj.eye.6702480","article-title":"Pterygium treatment using 5-FU as adjuvant treatment compared to conjunctiva autograft","volume":"22","author":"Bekibele","year":"2008","journal-title":"Eye"},{"key":"10.1016\/j.jtos.2022.08.002_bib75","doi-asserted-by":"crossref","DOI":"10.1111\/j.1755-3768.2008.564.x","article-title":"The use of intralesional injection of 5 fluorouracil to induce regression of recurrent pterygium","volume":"86","author":"Rahman","year":"2008","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.jtos.2022.08.002_bib76","first-page":"367","article-title":"An overview of management of pterygium in Nigeria","volume":"1","author":"Onwasigwe","year":"2008","journal-title":"Int J Ophthalmol"},{"key":"10.1016\/j.jtos.2022.08.002_bib77","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1001\/archopht.1995.01100110016008","article-title":"Inefficacy of low-dose intraoperative fluorouracil in the treatment of primary pterygium","volume":"113","author":"Maldonado","year":"1995","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jtos.2022.08.002_bib78","first-page":"57","article-title":"Prevention of pterygium recurrence by using intra-operative 5-fluorouracil","volume":"58","author":"Lu","year":"2008","journal-title":"PAFMJ"},{"key":"10.1016\/j.jtos.2022.08.002_bib79","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1590\/S0004-27492009000200007","article-title":"[Safety and efficacy of intraoperative 5-fluorouracil infiltration in pterygium treatment]","volume":"72","author":"Valezi","year":"2009","journal-title":"Arq Bras Oftalmol"},{"key":"10.1016\/j.jtos.2022.08.002_bib80","doi-asserted-by":"crossref","first-page":"8581","DOI":"10.14260\/jemds\/1494","article-title":"Comparison of surgical techniques for pterygium using mitomycin-C or 5-fluorouracil as adjuncts","volume":"2","author":"Kuldeep","year":"2013","journal-title":"J Evol Med Dent Sci"},{"key":"10.1016\/j.jtos.2022.08.002_bib81","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s10792-011-9509-x","article-title":"5-Fluorouracil versus mitomycin C as adjuncts to conjunctival autograft in preventing pterygium recurrence","volume":"32","author":"Bekibele","year":"2012","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.jtos.2022.08.002_bib82","first-page":"499","article-title":"Preoperative 5-fluorouracil infiltration in pterygium surgery","volume":"66","author":"Shiratori","year":"2003","journal-title":"Arq Bras Oftalmol"},{"key":"10.1016\/j.jtos.2022.08.002_bib83","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1097\/ICO.0000000000002545","article-title":"Long-term results of P.E.R.F.E.C.T. For PTERYGIUM","volume":"40","author":"Hirst","year":"2021","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2022.08.002_bib84","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.ophtha.2009.01.044","article-title":"Recurrent pterygium surgery using pterygium extended removal followed by extended conjunctival transplant: recurrence rate and cosmesis","volume":"116","author":"Hirst","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtos.2022.08.002_bib85","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1001\/archophthalmol.2012.2599","article-title":"Limbal-conjunctival vs conjunctival autograft transplant for recurrent pterygia: a prospective randomized controlled trial","volume":"131","author":"Al Fayez","year":"2013","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.jtos.2022.08.002_bib86","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1136\/bjo.84.4.385","article-title":"Analysis of variation in success rates in conjunctival autografting for primary and recurrent pterygium","volume":"84","author":"Ti","year":"2000","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jtos.2022.08.002_bib87","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1097\/ICO.0000000000000461","article-title":"Cadaveric porcine model for teaching and practicing conjunctival autograft creation","volume":"34","author":"Kuo","year":"2015","journal-title":"Cornea"},{"issue":"3","key":"10.1016\/j.jtos.2022.08.002_bib88","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/17469899.2017.1324297","article-title":"New treatment options for pterygium","volume":"12","author":"Fuest","year":"2017","journal-title":"Expet Rev Ophthalmol"},{"key":"10.1016\/j.jtos.2022.08.002_bib89","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1097\/ICO.0000000000001230","article-title":"Femtosecond laser assisted pterygium surgery","volume":"36","author":"Fuest","year":"2017","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2022.08.002_bib90","doi-asserted-by":"crossref","first-page":"191","DOI":"10.5935\/0004-2749.20210058","article-title":"Postoperative intralesional 5-fluorouracil therapy for early recurrence management of pterygium","volume":"84","author":"Viveiros","year":"2021","journal-title":"Arq Bras Oftalmol"},{"key":"10.1016\/j.jtos.2022.08.002_bib91","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/eye.2013.142","article-title":"Effects of intraoperative steroid injection on the outcome of pterygium surgery","volume":"27","author":"Kheirkhah","year":"2013","journal-title":"Eye"},{"key":"10.1016\/j.jtos.2022.08.002_bib92","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S1542-0124(12)70031-9","article-title":"Ocular effects of cosmetic products and procedures","volume":"4","author":"Coroneo","year":"2006","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2022.08.002_bib93","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1016\/j.ophtha.2011.01.045","article-title":"Cosmesis after pterygium extended removal followed by extended conjunctival transplant as assessed by a new, web-based grading system","volume":"118","author":"Hirst","year":"2011","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1016\/j.jtos.2022.08.002_bib94","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1001\/archopht.1997.01100160405001","article-title":"Effect of pterygium morphology on pterygium recurrence in a controlled trial comparing conjunctival autografting with bare sclera excision","volume":"115","author":"Tan","year":"1997","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jtos.2022.08.002_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107921","article-title":"Efficacy of bevacizumab in the treatment of pterygium: an updated meta-analysis of randomized controlled trials","volume":"98","author":"Zhang","year":"2021","journal-title":"Int Immunopharm"},{"key":"10.1016\/j.jtos.2022.08.002_bib96","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s12886-017-0601-5","article-title":"Anti-fibrotic, anti-VEGF or radiotherapy treatments as adjuvants for pterygium excision: a systematic review and network meta-analysis","volume":"17","author":"Zeng","year":"2017","journal-title":"BMC Ophthalmol"},{"issue":"Suppl 2","key":"10.1016\/j.jtos.2022.08.002_bib97","first-page":"S215","article-title":"Role of post-operative topical corticosteroids in recurrence rate after pterygium excision with conjunctival autograft","volume":"86","author":"Yaisawang","year":"2003","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.jtos.2022.08.002_bib98","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3109\/02713680903395273","article-title":"Efficacy of topical bevacizumab for inhibiting growth of impending recurrent pterygium","volume":"35","author":"Fallah","year":"2010","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.jtos.2022.08.002_bib99","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3341\/kjo.2015.29.6.375","article-title":"A comparative study of topical mitomycin C, cyclosporine, and bevacizumab after primary pterygium surgery","volume":"29","author":"Hwang","year":"2015","journal-title":"Kor J Ophthalmol : Kor J Ophthalmol"},{"key":"10.1016\/j.jtos.2022.08.002_bib100","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3928\/15428877-20090430-03","article-title":"Topical cyclosporin A and mitomycin C injection as adjunctive therapy for prevention of primary pterygium recurrence","volume":"40","author":"Ib\u00e1\u00f1ez","year":"2009","journal-title":"Ophthalmic Surg Laser Imag"},{"key":"10.1016\/j.jtos.2022.08.002_bib101","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0181-5512(08)74384-5","article-title":"[Effectiveness of topical ciclosporin A treatment after excision of primary pterygium and limbal conjunctival autograft]","volume":"31","author":"Aydin","year":"2008","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.jtos.2022.08.002_bib102","doi-asserted-by":"crossref","first-page":"5659","DOI":"10.2147\/DDDT.S285752","article-title":"Long-term efficacy and safety of subconjunctival\/perilesional 5-fluorouracil injections for ocular surface squamous neoplasia","volume":"14","author":"Sun","year":"2020","journal-title":"Drug Des Dev Ther"},{"key":"10.1016\/j.jtos.2022.08.002_bib103","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.ajo.2010.01.015","article-title":"Phase I study of subconjunctival ranibizumab in patients with primary pterygium undergoing pterygium surgery","volume":"149","author":"Galor","year":"2010","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jtos.2022.08.002_bib104","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1097\/ICO.0b013e31820ca63f","article-title":"Subconjunctival bevacizumab immediately after excision of primary pterygium: the first clinical trial","volume":"30","author":"Shenasi","year":"2011","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2022.08.002_bib105","first-page":"22","article-title":"Subconjunctival bevacizumab for primary pterygium excision; a randomized clinical trial","volume":"9","author":"Razeghinejad","year":"2014","journal-title":"J Ophthalmic Vis Res"},{"key":"10.1016\/j.jtos.2022.08.002_bib106","first-page":"13","article-title":"The effect of different doses of subconjunctival bevacizumab on the recurrence rate of excised primary pterygium","author":"Razeghinejad","year":"2013","journal-title":"Bull Soc Belge Ophtalmol"},{"key":"10.1016\/j.jtos.2022.08.002_bib107","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1159\/000252980","article-title":"Preliminary results of subconjunctival bevacizumab in primary pterygium excision","volume":"43","author":"Razeghinejad","year":"2010","journal-title":"Ophthalmic Res"},{"key":"10.1016\/j.jtos.2022.08.002_bib108","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3928\/15428877-20120802-02","article-title":"Intraoperative subconjunctival bevacizumab as an adjunctive treatment in primary pterygium: a preliminary report","volume":"43","author":"Shahin","year":"2012","journal-title":"Ophthalmic Surg Laser Imag"},{"key":"10.1016\/j.jtos.2022.08.002_bib109","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/ceo.12140","article-title":"Randomized, controlled trial of conjunctival autografting combined with subconjunctival bevacizumab for primary pterygium treatment: 1-year follow-up","volume":"42","author":"Nava-Castaneda","year":"2014","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.jtos.2022.08.002_bib110","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1007\/s00417-020-04704-w","article-title":"Efficacy of bevacizumab injection after pterygium excision and limbal conjunctival autograft with limbal fixation suture","volume":"258","author":"Yang","year":"2020","journal-title":"Graefe's Archive for Clinical and Experimental Ophthalmology"},{"key":"10.1016\/j.jtos.2022.08.002_bib111","first-page":"512","article-title":"Does topical bevacizumab prevent postoperative recurrence after pterygium surgery with conjunctival autografting?","volume":"7","author":"Karalezli","year":"2014","journal-title":"Int J Ophthalmol"},{"key":"10.1016\/j.jtos.2022.08.002_bib112","doi-asserted-by":"crossref","DOI":"10.1097\/ICO.0b013e3182772d4e","article-title":"Topical application of bevacizumab as an adjunct to recurrent pterygium surgery","volume":"32","author":"Ozgurhan","year":"2013","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2022.08.002_bib113","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s10792-015-0076-4","article-title":"A comparative study of different concentrations of topical bevacizumab on the recurrence rate of excised primary pterygium: a short-term follow-up study","volume":"36","author":"Motarjemizadeh","year":"2016","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.jtos.2022.08.002_bib114","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/ICO.0b013e3182151e0e","article-title":"Randomized controlled trial of subconjunctival bevacizumab injection in impending recurrent pterygium: a pilot study","volume":"31","author":"Lekhanont","year":"2012","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2022.08.002_bib115","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s10792-013-9852-1","article-title":"Subconjunctival bevacizumab in the impending recurrent pterygia","volume":"34","author":"Bayar","year":"2014","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.jtos.2022.08.002_bib116","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/ICO.0b013e3181822615","article-title":"Topical bevacizumab eyedrops for limbal-conjunctival neovascularization in impending recurrent pterygium","volume":"28","author":"Wu","year":"2009","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2022.08.002_bib117","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/02713680701799101","article-title":"Subconjunctival bevacizumab injection for corneal neovascularization in recurrent pterygium","volume":"33","author":"Bahar","year":"2008","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.jtos.2022.08.002_bib118","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1089\/jop.2014.0060","article-title":"Triple subconjunctival bevacizumab injection for early corneal recurrent pterygium: one-year follow-up","volume":"31","author":"Nava-Casta\u00f1eda","year":"2015","journal-title":"J Ocul Pharmacol Therapeut"},{"key":"10.1016\/j.jtos.2022.08.002_bib119","doi-asserted-by":"crossref","first-page":"407","DOI":"10.4103\/0301-4738.120220","article-title":"Repeated bevacizumab injections versus mitomycin C in rotational conjunctival flap for prevention of pterygium recurrence","volume":"62","author":"Ozsutcu","year":"2014","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.jtos.2022.08.002_bib120","doi-asserted-by":"crossref","first-page":"4427","DOI":"10.21608\/ejhm.2019.44528","article-title":"A comparison between bevacizumab and mitomycin C in treatment of primary pterygium","volume":"76","author":"Nassar","year":"2019","journal-title":"The Egypt J Hospit Med"},{"key":"10.1016\/j.jtos.2022.08.002_bib121","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1097\/ICO.0000000000001035","article-title":"Autoconjunctival graft compromise after pterygium surgery in a patient receiving intravitreal anti-vascular endothelial growth factor injections","volume":"35","author":"Tan","year":"2016","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2022.08.002_bib122","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1001\/archopht.1992.01080200052023","article-title":"A randomized study of trabeculectomy and subconjunctival administration of fluorouracil in primary glaucomas","volume":"110","author":"Ophir","year":"1992","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jtos.2022.08.002_bib123","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1001\/archopht.1991.01080010014005","article-title":"Remission of anterior uveitis by subconjunctival fluorouracil","volume":"109","author":"Ophir","year":"1991","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jtos.2022.08.002_bib124","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1001\/archopht.126.10.1460","article-title":"Conjunctival autograft failure in eyes previously exposed to \u00df-radiation or mitomycin","volume":"126","author":"Assaad","year":"2008","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jtos.2022.08.002_bib125","first-page":"575","article-title":"Bilateral cicatricial ectropion following topical administration of 5-fluorouracil","volume":"13","author":"Galentine","year":"1981","journal-title":"Ann Ophthalmol"},{"key":"10.1016\/j.jtos.2022.08.002_bib126","article-title":"Fluorouracil filtering surgery study one-year follow-up","volume":"186","author":"Fluorouracil Filtering Surgery Study","year":"2018","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jtos.2022.08.002_bib127","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0002-9394(14)74224-2","article-title":"Serious corneal complications of glaucoma filtering surgery with postoperative 5-fluorouracil","volume":"103","author":"Knapp","year":"1987","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jtos.2022.08.002_bib128","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jcrs.2017.03.002","article-title":"Surgical techniques and adjuvants for the management of primary and recurrent pterygia","volume":"43","author":"Hovanesian","year":"2017","journal-title":"J Cataract Refract Surg"},{"key":"10.1016\/j.jtos.2022.08.002_bib129","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/BF00951807","article-title":"Decreased corneal complications after no-reflux, low-dose 5 fluorouracil subconjunctival injection following trabeculectomy","volume":"18","author":"Traverso","year":"1994","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.jtos.2022.08.002_bib130","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/S0161-6420(92)31749-X","article-title":"Serious complications of topical mitomycin-C after pterygium surgery","volume":"99","author":"Rubinfeld","year":"1992","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtos.2022.08.002_bib131","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1159\/000310424","article-title":"Corneoscleral ulceration and corneal perforation after pterygium excision and topical mitomycin C therapy","volume":"207","author":"Fujitani","year":"1993","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.jtos.2022.08.002_bib132","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0002-9394(14)76738-8","article-title":"Development of scleral ulceration and calcification after pterygium excision and mitomycin therapy","volume":"112","author":"Dunn","year":"1991","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jtos.2022.08.002_bib133","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/ICU.0b013e3281a7ecbb","article-title":"Current concepts and techniques in pterygium treatment","volume":"18","author":"Ang","year":"2007","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.jtos.2022.08.002_bib134","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1442-9071.2006.01195.x","article-title":"Mitomycin C in the treatment of pterygium","volume":"34","author":"Hirst","year":"2006","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.jtos.2022.08.002_bib135","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1136\/bjo.81.10.877","article-title":"Incidence of delayed onset infection after trabeculectomy with adjunctive mitomycin C or 5-fluorouracil treatment","volume":"81","author":"Mochizuki","year":"1997","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jtos.2022.08.002_bib136","first-page":"698","article-title":"Pterygium and genetic polymorphisms of the DNA repair enzymes XRCC1, XPA, and XPD","volume":"16","author":"Chiang","year":"2010","journal-title":"Mol Vis"},{"issue":"Suppl 1","key":"10.1016\/j.jtos.2022.08.002_bib137","first-page":"S2","article-title":"Prevalence of pterygium and pinguecula: the blue mountains eye study","volume":"26","author":"Panchapakesan","year":"1998","journal-title":"Aust N Z J Ophthalmol"},{"key":"10.1016\/j.jtos.2022.08.002_bib138","article-title":"Conjunctival ultraviolet autofluorescence area decreases with age and sunglasses use","author":"Lingham","year":"2021","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jtos.2022.08.002_bib139","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/IJG.0b013e3181911271","article-title":"Long-term outcomes of needle revision of trabeculectomy blebs with mitomycin C and 5-fluorouracil: a comparative safety and efficacy report","volume":"18","author":"Anand","year":"2009","journal-title":"J Glaucoma"},{"key":"10.1016\/j.jtos.2022.08.002_bib140","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/S0002-9394(14)74454-X","article-title":"Late complications after glaucoma filtering surgery with adjunctive 5-fluorouracil","volume":"115","author":"Ticho","year":"1993","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jtos.2022.08.002_bib141","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1136\/bjo.77.4.250","article-title":"Serious corneal complication of 5-fluorouracil","volume":"77","author":"Hickey-Dwyer","year":"1993","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jtos.2022.08.002_bib142","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.ophtha.2016.02.034","article-title":"Topical 5-fluorouracil 1% as primary treatment for ocular surface squamous neoplasia","volume":"123","author":"Joag","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtos.2022.08.002_bib143","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1136\/bjophthalmol-2016-309219","article-title":"Topical 1% 5-fluoruracil as a sole treatment of corneoconjunctival ocular surface squamous neoplasia: long-term study","volume":"101","author":"Parrozzani","year":"2017","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jtos.2022.08.002_bib144","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/ceo.12377","article-title":"Management of diffuse ocular surface squamous neoplasia: efficacy and complications of topical chemotherapy","volume":"43","author":"Rudkin","year":"2015","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.jtos.2022.08.002_bib145","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/ceo.12184","article-title":"Long-term outcomes after adjunctive topical 5-flurouracil or mitomycin C for the treatment of surgically excised, localized ocular surface squamous neoplasia","volume":"42","author":"Bahrami","year":"2014","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.jtos.2022.08.002_bib146","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1136\/bjo.2010.183244","article-title":"Topical 1% 5-fluorouracil in ocular surface squamous neoplasia: a long-term safety study","volume":"95","author":"Parrozzani","year":"2011","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jtos.2022.08.002_bib147","article-title":"A case of sight threatening complications from topical 1% 5-fluorouracil in the treatment of ocular surface squamous neoplasia","volume":"25","author":"Lin","year":"2022","journal-title":"Am J Ophthalmol Case Rep"},{"key":"10.1016\/j.jtos.2022.08.002_bib148","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.2147\/DDDT.S191161","article-title":"Ocular surface squamous neoplasia: angiographic characteristics and response to subconjunctival\/perilesional 5-fluorouracil injections","volume":"13","author":"Sun","year":"2019","journal-title":"Drug Des Dev Ther"},{"key":"10.1016\/j.jtos.2022.08.002_bib149","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S0161-6420(91)32177-8","article-title":"Late bleb-related endophthalmitis after trabeculectomy with adjunctive 5-fluorouracil","volume":"98","author":"Wolner","year":"1991","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtos.2022.08.002_bib150","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1038\/eye.2011.209","article-title":"Surgical treatment of necrotic scleral calcification using combined conjunctival autografting and an amniotic membrane inlay filling technique","volume":"25","author":"Kim","year":"2011","journal-title":"Eye"}],"container-title":["The Ocular Surface"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154201242200074X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154201242200074X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:47:13Z","timestamp":1761540433000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S154201242200074X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":150,"alternative-id":["S154201242200074X"],"URL":"https:\/\/doi.org\/10.1016\/j.jtos.2022.08.002","relation":{},"ISSN":["1542-0124"],"issn-type":[{"value":"1542-0124","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"5-Fluorouracil in primary, impending recurrent and recurrent pterygium: Systematic review of the efficacy and safety of a surgical adjuvant and intralesional antimetabolite","name":"articletitle","label":"Article Title"},{"value":"The Ocular Surface","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtos.2022.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}